Skip to main content

Inpharmatica, Serono Expand Proteomics Deal

NEW YORK, Jan. 28-Inpharmatica and Serono are expanding their proteomics  collaboration, the two companies said this morning.


The two firms struck a collaboration in mid-2001 in which Inpharmatica supplies Serono with protein sequences to aid in drug and drug target discovery.


This agreement expands the deal, so that Inpharmatica will provide additional proprietary genomic sequence data from other protein families.


Inpharmatica will receive milestone and royalty payments based on any products developed, as well as additional research funding.


Inpharmatica, based in London, uses informatics and a large compute farm to analyze protein data for drug discovery.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.